Toxicological findings of synthetic cannabinoids in recreational users

Journal of Analytical Toxicology

Volumn 37, Issue 8, 2013, Pages 534-541

  Kronstrand, Robert ^a,b   Roman, Markus ^a   Andersson, Mikael ^a   Eklund, Arne ^a  

^a National Board of Forensic Medicine   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; AM 2201; AM 2233; AM 694; CANNABINOID; JR 144; JWH 007; JWH 019; JWH 020; JWH 073; JWH 073 METHYL; JWH 081; JWH 098; JWH 122; JWH 147; JWH 200; JWH 251; JWH 398; MAM 2201; RCS 4; RCS 4 ORTHO; RCS 8; UNCLASSIFIED DRUG; UR 144;

ACCURACY; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG USE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PROCEDURES; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RECREATION; SMOKING; STANDARD; TANDEM MASS SPECTROMETRY; TOXICITY TESTING;

ADOLESCENT; ADULT; CALIBRATION; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SWEDEN; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84888867913     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt068     Document Type: Article

References (42)

1. Vardakou, I., Pistos, C., Spiliopoulou, C. (2010) Spice drugs as a new trend: mode of action, identification and legislation. Toxicology Letters, 197, 157-162.
2. Auwarter, V., Dresen, S.,Weinmann,W., Muller, M., Putz, M., Ferreiros, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs. Journal of Mass Spectrometry, 44, 832-837.
3. Ernst, L., Schiebel, H.M., Theuring, C., Lindigkeit, R., Beuerle, T. (2011) Identification and characterization of JWH-122 used as new ingredient in 'Spice-like' herbal incenses. Forensic Science International, 208, e31-e35.
4. Huffman, J.W., Zengin, G., Wu, M.J. et al. (2005) Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorganic and Medicinal Chemistry, 13, 89-112.
5. Wiley, J.L., Compton, D.R., Dai, D. et al. (1998) Structure-activity relationships of indole- and pyrrole-derived cannabinoids. Journal of Pharmacology and Experimental Therapeutics, 285, 995-1004.
6. Dargan, P.I., Hudson, S., Ramsey, J., Wood, D.M. (2011) The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. International Journal of Drug Policy, 22, 274-277.
7. Denooz, R., Vanheugen, J.C., Frederich, M., de Tullio, P., Charlier, C. (2013) Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products. Journal of Analytical Toxicology, 37, 56-63.
8. Shanks, K.G., Dahn, T., Behonick, G., Terrell, A. (2012) Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. Journal of Analytical Toxicology, 36, 360-371.
9. Kavanagh, P., Grigoryev, A., Savchuk, S., Mikhura, I., Formanovsky, A. (2013) UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. Drug Testing and Analysis doi: 10.1002/dta.1456.
10. Compton, D.R., Rice, K.C., De Costa, B.R. et al. (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. Journal of Pharmacology and Experimental Therapeutics, 265, 218-226.
11. Little, P.J., Compton, D.R., Johnson, M.R., Melvin, L.S., Martin, B.R. (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. Journal of Pharmacology and Experimental Therapeutics, 247, 1046-1051.
12. Aung, M.M., Griffin, G., Huffman, J.W. et al. (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Dependence, 60, 133-140.
13. Atwood, B.K., Huffman, J., Straiker, A., Mackie, K. (2010) JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. British Journal of Pharmacology, 160, 585-593.
14. Every-Palmer, S. (2010) Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105, 1859-1860.
15. Lapoint, J., James, L.P., Moran, C.L., Nelson, L.S., Hoffman, R.S., Moran, J.H. (2011) Severe toxicity following synthetic cannabinoid ingestion. Clinical Toxicology (Phila), 49, 760-764.
16. Schneir, A.B., Cullen, J., Ly, B.T. (2011) 'Spice' girls: synthetic cannabinoid intoxication. Journal of Emergency Medicine, 40, 296-299.
17. Brents, L.K., Reichard, E.E., Zimmerman, S.M., Moran, J.H., Fantegrossi, W.E., Prather, P.L. (2011) Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One, 6, e21917.
18. Halberstadt, A.L., Geyer, M.A. (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 61, 364-381.
19. Heinz, A., Schlagenhauf, F. (2010) Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophrenia Bulletin, 36, 472-485.
20. Javitt, D.C. (2010) Glutamatergic theories of schizophrenia. Isrrael Journal of Psychiatry and Related Science, 47, 4-16.
21. Deyama, S., Takishita, A., Tanimoto, S. et al. (2010) Roles of beta- and alpha2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. Journal of Pharmacological Sciences, 114, 123-126.
22. Durant, C., Christmas, D., Nutt, D. (2010) The pharmacology of anxiety. Current Topics in Behavioural Neuroscience, 2, 303-330.
23. Hurlemann, R.,Walter, H., Rehme, A.K. et al. (2010) Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychological Medicine, 40, 1839-1848.
24. Mares, P., Mikulecka, A., Ticha, K., Lojkova-Janeckova, D., Kubova, H. (2010) Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats. Epilepsia, 51(Suppl 3), 24-26.
25. Young, A.C., Schwarz, E., Medina, G. et al. (2012) Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. American Journal of Emergency Medicine 30, e5-7.
26. Seely, K.A., Prather, P.L., James, L.P., Moran, J.H. (2011) Marijuanabased drugs: innovative therapeutics or designer drugs of abuse. Molecular Interventions, 11, 36-51.
27. Shanks, K.G., Dahn, T., Terrell, A.R. (2012) Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. Journal of Analytical Toxicology, 36, 145-152.
28. Zimmermann, U.S., Winkelmann, P.R., Pilhatsch, M., Nees, J.A., Spanagel, R., Schulz, K. (2009) Withdrawal phenomena and dependence syndrome after the consumption of 'spice gold'. Deutsches Aerzteblatt International, 106, 464-467.
29. Bononi, M., Belgi, P., Tateo, F. (2011) Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203. Journal of Analytical Toxicology, 35, 360-363.
30. Hudson, S., Ramsey, J., King, L. et al. (2010) Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in 'herbal high' products. Journal of Analytical Toxicology, 34, 252-260.
31. Uchiyama, N., Kikura-Hanajiri, R., Shoda, T., Fukuhara, K., Goda, Y. (2011) Isomeric analysis of synthetic cannabinoids detected as designer drugs. Yakugaku Zasshi, 131, 1141-1147.
32. Teske, J., Weller, J.P., Fieguth, A., Rothamel, T., Schulz, Y., Troger, H.D. (2010) Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 878, 2659-2663.
33. Kacinko, S.L., Xu, A., Homan, J.W., McMullin, M.M., Warrington, D.M., Logan, B.K. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. Journal of Analytical Toxicology, 35, 386-393.
34. Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., Auwarter, V. (2011) Development and validation of a liquid chromatographytandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163-171.
35. Ammann, J., McLaren, J.M., Gerostamoulos, D., Beyer, J. (2012) Detection and quantification of new designer drugs in human blood: part 1-synthetic cannabinoids. Journal of Analytical Toxicology, 36, 372-380.
36. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
37. Kneisel, S., Auwarter, V. (2012) Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. Journal of Mass Spectrometry, 47, 825-835.
38. Gunderson, E.W., Haughey, H.M., Ait-Daoud, N., Joshi, A.S., Hart, C.L. (2012) 'Spice' and 'K2' herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. American Journal of Addiction, 21, 320-326.
39. Hermanns-Clausen, M., Kneisel, S., Szabo, B., Auwarter, V. (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534-544.
40. Seely, K.A., Lapoint, J., Moran, J.H., Fattore, L. (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuropsychopharmacology and Biology Psychiatry, 39, 234-243.
41. Simmons, J., Cookman, L., Kang, C., Skinner, C. (2011) Three cases of 'spice' exposure. Clinical Toxicology (Phila), 49, 431-433.
42. Simmons, J.R., Skinner, C.G., Williams, J., Kang, C.S., Schwartz, M.D., Wills, B.K. (2011) Intoxication from smoking 'spice'. Annals of Emergency Medicine, 57, 187-188.